集采规则新变！不再简单选用最低报价，新增“未入围复活”

Core Points - The latest progress in the 11th batch of centralized drug procurement has been announced, focusing on principles such as ensuring clinical needs, maintaining quality, preventing collusion, and avoiding excessive competition [1] - The new procurement rules allow medical institutions to report quantities based on specific brands, with 77% of reports now detailing brands, which enhances the match between clinical demand and supply [1][2] - A new "revival for non-selected" rule has been introduced, allowing companies that did not initially qualify to enter the selection process under certain conditions [2][3] - The procurement process will prioritize children's medication supply, with adjusted pricing rules for small specifications suitable for children [3] - New qualification requirements for bidders include a minimum of two years of production experience and compliance with GMP standards [4][5] - A "first report leniency" mechanism has been introduced to combat collusion, allowing companies that provide evidence of collusion to receive more lenient treatment [6][7] - The procurement process will no longer simply select the lowest bid, with new rules to prevent extreme low pricing and ensure fair competition [9][10] Group 1 - The 11th batch of centralized drug procurement has been published, emphasizing principles like ensuring clinical needs and maintaining quality [1] - Medical institutions can now report quantities based on specific brands, with 77% of reports detailing brands [1][2] - The "revival for non-selected" rule allows companies that did not qualify to enter the selection process under specific conditions [2][3] Group 2 - The procurement process will prioritize children's medication supply with adjusted pricing rules for small specifications [3] - New qualification requirements for bidders include a minimum of two years of production experience and compliance with GMP standards [4][5] - A "first report leniency" mechanism has been introduced to combat collusion [6][7] Group 3 - The procurement process will no longer simply select the lowest bid, with new rules to prevent extreme low pricing [9][10] - The new rules aim to ensure fair competition and maintain quality standards in the procurement process [4][5][6]